Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases Jan 11, 2021 06:00AM
George O. Elston Named Chief Executive Officer of 2X Oncology May 30, 2017 12:26PM
Neuralstem Reports Third Quarter 2015 Financial Results Nov 9, 2015 09:03AM
Juniper Appointed Partner For Groundbreaking Cancer Drug Delivery Platform Jun 23, 2015 06:55AM